Paper39458571
Combination Therapy and Phytochemical-Loaded Nanosytems for the Treatment of Neglected Tropical Diseases.
Soto-Sánchez J and 1 other. Pharmaceutics, 2024. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Combination Therapy and Phytochemical-Loaded Nanosytems for the Treatment of Neglected Tropical Diseases. Papers, record 39458571. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39458571
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Combination Therapy and Phytochemical-Loaded Nanosytems for the Treatment of Neglected Tropical Diseases.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References168
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29705579 | Melarsoprol Resistance in African Trypanosomiasis. | Trends Parasitol | 2018 | https://conductscience.org/library/papers/29705579 | PubMed |
| 2 | 29268964 | Natural compounds and extracts from Mexican medicinal plants with anti-leishmaniasis activity: An update. | Asian Pac J Trop Med | 2017 | https://conductscience.org/library/papers/29268964 | PubMed |
| 3 | 25768915 | Effect of Apigenin on Leishmania amazonensis Is Associated with Reactive Oxygen Species Production Followed by Mitochondrial Dysfunction. | J Nat Prod | 2015 | https://conductscience.org/library/papers/25768915 | PubMed |
| 4 | 36781499 | The Therapeutic Effects of Curcumin-coated Gold Nanoparticle Against Leishmania Major Causative Agent of Zoonotic Cutaneous Leishmaniasis (ZCL): An In Vitro and In Vivo Study. | Curr Microbiol | 2023 | https://conductscience.org/library/papers/36781499 | PubMed |
| 5 | 35998724 | In vivo schistosomicidal activity of (±)-licarin A-loaded poly(ε-caprolactone) nanoparticles. | Exp Parasitol | 2022 | https://conductscience.org/library/papers/35998724 | PubMed |
| 6 | 27875592 | Curcumin Generates Oxidative Stress and Induces Apoptosis in Adult Schistosoma mansoni Worms. | PLoS One | 2016 | https://conductscience.org/library/papers/27875592 | PubMed |
| 7 | 37033490 | Protective effects of Theracurmin treatment during experimental infection of the Colombian strain of Trypanosoma cruzi at the testicular site. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/37033490 | PubMed |
| 8 | 36985306 | Synthesis of Carvacrol-Loaded Invasomes Nanoparticles Improved Acaricide Efficacy, Cuticle Invasion and Inhibition of Acetylcholinestrase against Hard Ticks. | Microorganisms | 2023 | https://conductscience.org/library/papers/36985306 | PubMed |
| 9 | 31676458 | (±)-Licarin A and its semi-synthetic derivatives: In vitro and in silico evaluation of trypanocidal and schistosomicidal activities. | Acta Trop | 2020 | https://conductscience.org/library/papers/31676458 | PubMed |
| 10 | 36430948 | Drug Combination Studies of the Dipeptide Nitrile CD24 with Curcumin: A New Strategy to Synergistically Inhibit Rhodesain of Trypanosoma brucei rhodesiense. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36430948 | PubMed |
| 11 | 31786952 | Development and evaluation of novel miltefosine-polyphenol co-loaded second generation nano-transfersomes for the topical treatment of cutaneous leishmaniasis. | Expert Opin Drug Deliv | 2020 | https://conductscience.org/library/papers/31786952 | PubMed |
| 12 | 33002744 | Lupeol and amphotericin B mediate synergistic anti-leishmanial immunomodulatory effects in Leishmania donovani-infected BALB/c mice. | Cytokine | 2021 | https://conductscience.org/library/papers/33002744 | PubMed |
| 13 | 32848491 | The Efficacy and Safety of Highly-Bioavailable Curcumin for Treating Knee Osteoarthritis: A 6-Month Open-Labeled Prospective Study. | Clin Med Insights Arthritis Musculoskelet Disord | 2020 | https://conductscience.org/library/papers/32848491 | PubMed |
| 14 | 36423002 | Chitosan-Based Nanomaterial as Immune Adjuvant and Delivery Carrier for Vaccines. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/36423002 | PubMed |
| 15 | 31104636 | Lupeol induces immunity and protective efficacy in a murine model against visceral leishmaniasis. | Parasitology | 2019 | https://conductscience.org/library/papers/31104636 | PubMed |
| 16 | 37091674 | Apigenin is a promising molecule for treatment of visceral leishmaniasis. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/37091674 | PubMed |
| 17 | 35453582 | Potential of Triterpenic Natural Compound Betulinic Acid for Neglected Tropical Diseases New Treatments. | Biomedicines | 2022 | https://conductscience.org/library/papers/35453582 | PubMed |
| 18 | 35708415 | Plant-derived compounds for the treatment of schistosomiasis: Improving efficacy via nano-drug delivery. | Niger J Clin Pract | 2022 | https://conductscience.org/library/papers/35708415 | PubMed |
| 19 | 22264477 | New ionic derivatives of betulinic acid as highly potent anti-cancer agents. | Bioorg Med Chem Lett | 2012 | https://conductscience.org/library/papers/22264477 | PubMed |
| 20 | 16569852 | Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/16569852 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42860538 | Antileishmanial potential of polar fractions from Amaranthus blitoides S. Watson, Caucalis platycarpos L., and Cistanche flava (C.A.Mey.) Korsh.: evidence from in vitro and in vivo studies. | Trop Med Health | 2026 | https://conductscience.org/library/papers/42860538 | PubMed |
| 42395961 | Curcumin Nanoencapsulated in Chitosan-Coated Liposomes: Therapeutic Potential against Pathogenic Escherichia coli and Leishmania spp. | ACS Omega | 2026 | https://conductscience.org/library/papers/42395961 | PubMed |
| 41977496 | Synthesis of New Asymmetrical Chalcones and Evaluation of Their Use in Combination with Curcumin Against Rhodesain of T. brucei rhodesiense. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977496 | PubMed |
| 41715893 | Mitigating PM2.5-induced skin injury and aging: botanical strategies targeting redox and inflammatory pathways. | Redox Rep | 2026 | https://conductscience.org/library/papers/41715893 | PubMed |
| 41155688 | A Review on Phytochemistry, Ethnopharmacology, and Antiparasitic Potential of Mangifera indica L. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41155688 | PubMed |
| 40840747 | Green synthesis of demethoxycurcumin-loaded chitosan nanoparticles for the management of potato late blight caused by Phytophthora infestans. | Int J Biol Macromol | 2025 | https://conductscience.org/library/papers/40840747 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39458571
GET https://conductscience.org/api/papers/v1/39458571/references?page=2